{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:58:40Z","timestamp":1789883920514,"version":"4.0.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T00:00:00Z","timestamp":1441238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Angiopoietin-2 (Ang-2) is a mediator of capillary leakage, and increased Ang-2 levels were associated with poor in-hospital outcome in a pilot study in cardiogenic shock (CS). In this larger study, we followed this hypothesis and aimed at assessing the predictive role of Ang-2 on short- and long-term mortality, investigating the effect of intra-aortic balloon pump (IABP) treatment on Ang-2 levels, and identifying clinical and procedural predictors of increased Ang-2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In the IABP-SHOCK II-trial, 600 patients with CS complicating acute myocardial infarction were assigned to therapy with or without IABP. This substudy included 189 randomized patients with serial blood sampling performed at days 1, 2, and 3. No significant differences in Ang-2 levels were found between patients with or without IABP. The Ang-2 levels above the median at day 1 were associated with 30-day [hazard ratio (HR) 1.98, 95% confidence interval (CI) 1.26\u20133.10, P = 0.002) and 1-year mortality (HR 2.21, 95% CI 1.49\u20133.27, P &amp;lt; 0.001). Stratification of patients according to Ang-2 levels at day 3 increased these associations (30 days HR 5.15, 95% CI 2.80\u20139.45, P &amp;lt; 0.001; 1 year HR 5.24, 95% CI 3.19\u20138.58, P &amp;lt; 0.001). The Ang-2 concentrations were independent predictors for mortality in multivariate analysis (30 days HR 4.82, 95% CI 1.52\u201315.23, P = 0.007; 1 year HR 2.01, 95%CI 1.24\u20133.24, P = 0.005). Predictors of increased Ang-2 levels at day 3 were baseline Ang-2, development of acute kidney injury, bleeding events or transfusion, and impaired reperfusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In CS, high levels of Ang-2 are independently associated with poor short- and long-term outcome and associated with the reperfusion success as well as complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial Registration<\/jats:title>\n                    <jats:p>URL: www.clinicaltrials.gov; unique identifier: NCT00491036<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.342","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T02:33:39Z","timestamp":1441247619000},"page":"1152-1160","source":"Crossref","is-referenced-by-count":58,"title":["Angiopoietin-2 in Acute Myocardial Infarction Complicated by Cardiogenic Shock\u2014a Biomarker Substudy of the IABP-SHOCK II-Trial"],"prefix":"10.1093","volume":"17","author":[{"given":"Janine","family":"P\u00f6ss","sequence":"first","affiliation":[{"name":"Medical Clinic II\/Cardiology\/Angiology\/Intensive Care Medicine, University Heart Centre L\u00fcbeck, University Hospital Schleswig-Holstein (UKSH) , Ratzeburger Allee 160, 23538, L\u00fcbeck ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Fuernau","sequence":"additional","affiliation":[{"name":"Medical Clinic II\/Cardiology\/Angiology\/Intensive Care Medicine, University Heart Centre L\u00fcbeck, University Hospital Schleswig-Holstein (UKSH) , Ratzeburger Allee 160, 23538, L\u00fcbeck ,","place":["Germany"]},{"name":"Clinic for Internal Medicine\/Cardiology, University of Leipzig \u2013 Heart Centre , Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Denks","sequence":"additional","affiliation":[{"name":"Clinic for Internal Medicine\/Cardiology, University of Leipzig \u2013 Heart Centre , Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Desch","sequence":"additional","affiliation":[{"name":"Medical Clinic II\/Cardiology\/Angiology\/Intensive Care Medicine, University Heart Centre L\u00fcbeck, University Hospital Schleswig-Holstein (UKSH) , Ratzeburger Allee 160, 23538, L\u00fcbeck ,","place":["Germany"]},{"name":"Clinic for Internal Medicine\/Cardiology, University of Leipzig \u2013 Heart Centre , Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Eitel","sequence":"additional","affiliation":[{"name":"Medical Clinic II\/Cardiology\/Angiology\/Intensive Care Medicine, University Heart Centre L\u00fcbeck, University Hospital Schleswig-Holstein (UKSH) , Ratzeburger Allee 160, 23538, L\u00fcbeck ,","place":["Germany"]},{"name":"Clinic for Internal Medicine\/Cardiology, University of Leipzig \u2013 Heart Centre , Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"de Waha","sequence":"additional","affiliation":[{"name":"Clinic for Internal Medicine\/Cardiology, University of Leipzig \u2013 Heart Centre , Leipzig ,","place":["Germany"]},{"name":"Herzzentrum, Segeberger Kliniken GmbH , Bad Segeberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Link","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universit\u00e4tsklinikum des Saarlandes , Homburg\/Saar ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Schuler","sequence":"additional","affiliation":[{"name":"Clinic for Internal Medicine\/Cardiology, University of Leipzig \u2013 Heart Centre , Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Adams","sequence":"additional","affiliation":[{"name":"Clinic for Internal Medicine\/Cardiology, University of Leipzig \u2013 Heart Centre , Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universit\u00e4tsklinikum des Saarlandes , Homburg\/Saar ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[{"name":"Medical Clinic II\/Cardiology\/Angiology\/Intensive Care Medicine, University Heart Centre L\u00fcbeck, University Hospital Schleswig-Holstein (UKSH) , Ratzeburger Allee 160, 23538, L\u00fcbeck ,","place":["Germany"]},{"name":"Clinic for Internal Medicine\/Cardiology, University of Leipzig \u2013 Heart Centre , Leipzig ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,9,3]]},"reference":[{"key":"2026011921102757300_ejhf342-bib-0001","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/CIRCULATIONAHA.106.613596","article-title":"Cardiogenic shock: current concepts and improving outcomes","volume":"117","author":"Reynolds","year":"2008","journal-title":"Circulation"},{"key":"2026011921102757300_ejhf342-bib-0002","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/cc7153","article-title":"Bench-to-bedside review: Angiopoietin signalling in critical illness \u2013 a future target?","volume":"13","author":"van Meurs","year":"2009","journal-title":"Crit Care"},{"key":"2026011921102757300_ejhf342-bib-0003","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.RES.86.1.24","article-title":"Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3\u2032-Kinase\/Akt signal transduction pathway","volume":"86","author":"Kim","year":"2000","journal-title":"Circ Res"},{"key":"2026011921102757300_ejhf342-bib-0004","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nm1351","article-title":"Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation","volume":"12","author":"Fiedler","year":"2006","journal-title":"Nat Med"},{"key":"2026011921102757300_ejhf342-bib-0005","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2003-10-3685","article-title":"The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Paladebodies","volume":"103","author":"Fiedler","year":"2004","journal-title":"Blood"},{"key":"2026011921102757300_ejhf342-bib-0006","doi-asserted-by":"crossref","first-page":"12171","DOI":"10.1074\/jbc.M305146200","article-title":"Hypoxic regulation of angiopoietin-2 expression in endothelial cells","volume":"279","author":"Pichiule","year":"2004","journal-title":"J Biol Chem"},{"key":"2026011921102757300_ejhf342-bib-0007","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1242\/jcs.01653","article-title":"The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism","volume":"118","author":"Scharpfenecker","year":"2005","journal-title":"J Cell Sci"},{"key":"2026011921102757300_ejhf342-bib-0008","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1097\/CCM.0b013e3181eaa5bf","article-title":"Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients","volume":"38","author":"Ong","year":"2010","journal-title":"Crit Care Med"},{"key":"2026011921102757300_ejhf342-bib-0009","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/cc7130","article-title":"Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients","volume":"12","author":"K\u00fcmpers","year":"2008","journal-title":"Crit Care"},{"key":"2026011921102757300_ejhf342-bib-0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.CCM.0000251640.77679.D7","article-title":"Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators","volume":"35","author":"Orfanos","year":"2007","journal-title":"Crit Care Med"},{"key":"2026011921102757300_ejhf342-bib-0011","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/CCM.0b013e318206d285","article-title":"Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis","volume":"39","author":"Ricciuto","year":"2011","journal-title":"Crit Care Med"},{"key":"2026011921102757300_ejhf342-bib-0012","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/eurheartj\/ehs487","article-title":"Circulating angiopoietins and cardiovascular mortality in cardiogenic shock","volume":"34","author":"Link","year":"2013","journal-title":"Eur Heart J"},{"key":"2026011921102757300_ejhf342-bib-0013","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ahj.2012.03.012","article-title":"Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial","volume":"163","author":"Thiele","year":"2012","journal-title":"Am Heart J"},{"key":"2026011921102757300_ejhf342-bib-0014","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(13)61783-3","article-title":"Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial","volume":"382","author":"Thiele","year":"2013","journal-title":"Lancet"},{"key":"2026011921102757300_ejhf342-bib-0015","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"2026011921102757300_ejhf342-bib-0016","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ejhf.117","article-title":"Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial","volume":"16","author":"Fuernau","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026011921102757300_ejhf342-bib-0017","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/cc6966","article-title":"Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays","volume":"12","author":"Lukasz","year":"2008","journal-title":"Crit Care"},{"key":"2026011921102757300_ejhf342-bib-0018","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"2026011921102757300_ejhf342-bib-0019","first-page":"371","article-title":"A Correction for the \u03f5\u0303 approximate test in repeated measures designs with two or more independent groups","volume":"16","author":"Lecoutre","year":"1991","journal-title":"J Educ Stat"},{"key":"2026011921102757300_ejhf342-bib-0020","first-page":"343","article-title":"German Cardiac Society; German Society of Intensive Care and Emergency Medicine; German Society for Thoracic and Cardiovascular Surgery; (Austrian Society of Internal and General Intensive Care Medicine; German Interdisciplinary Association of Intensive Care and Emergency Medicine; Austrian Society of Cardiology; German Society of Anaesthesiology and Intensive Care Medicine; German Society of Preventive Medicine and Rehabilitation. Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German\u2013Austrian S3 Guidelin","volume":"109","author":"Werdan","year":"2012","journal-title":"Dtsch Arztebl Int"},{"key":"2026011921102757300_ejhf342-bib-0021","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1186\/1471-2407-14-696","article-title":"Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer","volume":"14","author":"Sallinen","year":"2014","journal-title":"BMC Cancer"},{"key":"2026011921102757300_ejhf342-bib-0022","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1158\/0008-5472.CAN-12-4697","article-title":"Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy","volume":"73","author":"Gerald","year":"2013","journal-title":"Cancer Res"},{"key":"2026011921102757300_ejhf342-bib-0023","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1093\/ndt\/gfq060","article-title":"Circulating angiopoietin-2 levels increase with progress of chronic kidney disease","volume":"25","author":"David","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2026011921102757300_ejhf342-bib-0024","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00392-014-0787-y","article-title":"Angiopoietin-2 and outcome in patients with acute decompensated heart failure","volume":"104","author":"P\u00f6ss","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"2026011921102757300_ejhf342-bib-0025","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00134-009-1726-7","article-title":"Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome","volume":"36","author":"Kumpers","year":"2010","journal-title":"Intensive Care Med"},{"key":"2026011921102757300_ejhf342-bib-0026","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.342","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/17\/11\/1152\/66422298\/eurjhf_17_11_1152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/17\/11\/1152\/66422298\/eurjhf_17_11_1152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:11:07Z","timestamp":1768875067000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/17\/11\/1152\/8426448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,3]]},"references-count":26,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,9,3]]},"published-print":{"date-parts":[[2015,11,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.342","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,11]]},"published":{"date-parts":[[2015,9,3]]}}}